Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis
暂无分享,去创建一个
[1] T. Sternsdorf,et al. Nuclear dots: actors on many stages. , 1997, Immunobiology.
[2] H. Will,et al. Autoantibodies Against “Nuclear Dots” in Primary Biliary Cirrhosis , 1997, Seminars in liver disease.
[3] T. Sternsdorf,et al. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). , 1996, European journal of biochemistry.
[4] J. Courvalin,et al. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme‐linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis , 1996, Hepatology.
[5] J. Węsierska‐Gądek,et al. Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. , 1996, Gastroenterology.
[6] Y. Makino,et al. Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway. , 1996, Journal of immunology.
[7] P. Pandolfi,et al. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. , 1995, Oncogene.
[8] T. Sternsdorf,et al. Two Nuclear Dot‐Associated Proteins, PML and SplOO, are Often Co‐Autoimmunogenic in Patients with Primary Biliary Cirrhosis , 1995, Scandinavian journal of immunology.
[9] Charles E. Kahn,et al. primary biliary cirrhosis , 1995 .
[10] U. Steinbrecher,et al. The canadian multicenter double‐blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis , 1994, Hepatology.
[11] N. Stuurman,et al. The t(15;17) translocation alters a nuclear body in a retinoic acid‐reversible fashion. , 1994, The EMBO journal.
[12] R. Evans,et al. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein , 1994, Cell.
[13] Maria Carmo-Fonseca,et al. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells , 1994, Cell.
[14] G. Maul,et al. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). , 1993, The Journal of general virology.
[15] M. Snyder,et al. Nuclear dot antigens may specify transcriptional domains in the nucleus , 1993, Molecular and cellular biology.
[16] F. Lacaille,et al. The immunosuppressive effect of ursodeoxycholic acid: A comparative in vitro study on human peripheral blood mononuclear cells , 1993, Hepatology.
[17] A. Lamond,et al. The coiled body. , 1993, Trends in cell biology.
[18] H. Will,et al. IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. , 1992, Journal of immunology.
[19] H. Will,et al. Autoantibodies to the Nuclear Sp100 Protein in Primary Biliary Cirrhosis and Associated Diseases: Epitope Specificity and Immunoglobulin Class Distribution , 1992, Scandinavian journal of immunology.
[20] Y. Calmus,et al. Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor–α production by monocytes , 1992, Hepatology.
[21] Y. Matsumura,et al. Immunomodulatory effects of ursodeoxycholic acid on immune responses , 1992, Hepatology.
[22] M. Gossen,et al. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[23] C. Ascoli,et al. Identification of a novel nuclear domain , 1991, The Journal of cell biology.
[24] H. Will,et al. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. , 1990, Journal of immunology.
[25] Christine Chomienne,et al. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus , 1990, Nature.
[26] G. Blobel,et al. Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis , 1990, The Journal of experimental medicine.
[27] D. Dhumeaux,et al. Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis: A clinical and immune-logical study of a series of 150 patients with primary biliary cirrhosis , 1990 .
[28] R. Sprengel,et al. Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein , 1990, Journal of virology.
[29] P. Gane,et al. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: Effect of ursodeoxycholic acid , 1990, Hepatology.
[30] F. BordaCelaya,et al. [Primary biliary cirrhosis]. , 1989, Anales de medicina interna.
[31] I. Mackay,et al. Reactivity of primary biliary cirrhosis sera with a human fetal liver cDNA clone of branched‐chain α‐keto acid dehydrogenase dihydrolipoamide acyltransferase, the 52 kD mitochondrial autoantigen , 1989, Hepatology.
[32] J. Guest,et al. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[33] R. Coppel,et al. Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Plana,et al. Autoantibodies against nuclear envelope‐associated proteins in primary biliary cirrhosis , 1988, Hepatology.
[35] R. Coppel,et al. Autoantibodies to mitochondria in systemic sclerosis. Frequency and characterization using recombinant cloned autoantigen. , 1988, Arthritis and rheumatism.
[36] R. Klein,et al. 11 Immunology of primary biliary cirrhosis , 1987 .
[37] E. Penner,et al. Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). , 1987, Clinical and experimental immunology.
[38] E. Christensen,et al. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients , 1980 .
[39] R. Wozniak,et al. Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. , 1994, Gastroenterology.
[40] E. Tan,et al. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. , 1989, Advances in immunology.